Whitebox Advisors’s Zura Bio ZURA Stock Holding History

Whitebox Advisors’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-150,000	Closed	-$1.53M	–	592
2022 Q4	$1.53M	Hold	150,000	–	–	0.04%	215
2022 Q3	$1.51M	Hold	150,000	–	–	0.04%	234
2022 Q2	$1.49M	Hold	150,000	–	–	0.05%	232
2022 Q1	$1.49M	Hold	150,000	–	–	0.03%	249
2021 Q4	$1.48M	Buy	+150,000	New	+$1.48M	0.03%	243

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Whitebox Advisors's ZURA Position: Q1 2023 in Review

Whitebox Advisors sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 150,000 shares — an estimated $1.53M sold.

Whitebox Advisors first reported a position in ZURA in Q4 2021 and held it in 5 quarters. The position peaked at $1.53M in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Whitebox Advisors reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Whitebox Advisors sold 150,000 Zura Bio shares in Q1 2023, an estimated $1.53M.
Whitebox Advisors first reported a position in Zura Bio in Q4 2021 and held it in 5 quarters.
Whitebox Advisors's Zura Bio position peaked at $1.53M in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.